# Gabapentin for Pain Management During Dilation and Evacuation

> **NCT03635905** · PHASE4 · COMPLETED · sponsor: **Medstar Health Research Institute** · enrollment: 130 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Gabapentin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03635905
- **Lead sponsor:** Medstar Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-26
- **Primary completion:** 2019-05-09
- **Final completion:** 2020-05-20
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2020-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03635905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03635905, "Gabapentin for Pain Management During Dilation and Evacuation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03635905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*